CURANEX PHARMACEUTICALS INC (CURX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$5.78-0.34%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CURX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Operating Expenses & Income | ||||
| R&D Expenses | — | 3.0 | — | — |
| Operating Income | (10.6) | (4.2) | (0.4) | — |
| Earnings from Continuing Operations | ||||
| Interest Expense | — | 0.0 | — | — |
| Net Income | ||||
| Net Income | (10.5) | (4.2) | (0.4) | — |
| Per Share | ||||
| Basic EPS | (0.37) | (0.17) | (0.03) | — |
| Diluted EPS | (0.37) | (0.17) | (0.03) | — |
| Basic Weighted Avg Shares | 28.4 | 25.5 | 13.3 | — |
| Diluted Weighted Avg Shares | 28.4 | 25.5 | 13.3 | — |
| Supplemental | ||||
| EBIT | (10.6) | (4.2) | (0.4) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.